A Belfiore Selected Research

A Belfiore Research Topics

Disease

8	Neoplasms (Cancer) 01/2018 - 05/2000
4	Thyroid Neoplasms (Thyroid Cancer) 06/2012 - 05/2000
2	Pneumonia (Pneumonitis) 06/2022 - 04/2006
2	Insulin Resistance 08/2010 - 01/2009
2	Hyperinsulinism (Hyperinsulinemia) 01/2009 - 06/2005
2	Morbid Obesity 06/2005 - 03/2003
2	Papillary Thyroid Cancer 01/2002 - 05/2000
2	Neoplasm Metastasis (Metastasis) 01/2002 - 06/2000
2	Papillary Carcinoma 08/2001 - 06/2001
1	COVID-19 06/2022
1	Disease Progression 01/2021
1	Triple Negative Breast Neoplasms 01/2021
1	Circulating Neoplastic Cells 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2018
1	Carcinoma (Carcinomatosis) 01/2016
1	Laryngeal Neoplasms (Laryngeal Cancer) 01/2016
1	Iron Deficiencies 12/2015
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2014
1	Hyperandrogenism 02/2014
1	Hirsutism 02/2014
1	Adenoma (Adenomas) 03/2013
1	Sarcoma (Soft Tissue Sarcoma) 06/2011
1	Ewing Sarcoma (Sarcoma, Ewing) 06/2011
1	Non-alcoholic Fatty Liver Disease 08/2010
1	Fatty Liver 08/2010
1	Type 2 Diabetes Mellitus (MODY) 01/2009
1	Hyperprolactinemia 04/2008
1	Prolactinoma (Prolactinomas) 04/2008
1	Migraine Disorders (Migraine) 04/2008
1	Headache (Headaches) 04/2008
1	Pain (Aches) 04/2008
1	Myoclonus (Nocturnal Myoclonus) 04/2007
1	Chest Pain (Chest Pains) 04/2006
1	Cough 04/2006
1	Dyspnea (Shortness of Breath) 04/2006
1	Fever (Fevers) 04/2006
1	Weight Loss (Weight Reduction) 06/2005
1	Leukoencephalopathies 04/2004
1	Carotid Artery Diseases 03/2003
1	follicular Thyroid cancer 01/2002
1	Nodular Goiter 08/2001
1	Hypoparathyroidism 06/2000

Drug/Important Bio-Agent (IBA)

4	Insulin (Novolin)FDA Link 01/2018 - 06/2005
2	Protein Isoforms (Isoforms)IBA 01/2016 - 06/2001
2	Metformin (Glucophage)FDA LinkGeneric 02/2014 - 08/2010
2	Insulin-Like Growth Factor I (IGF-1)IBA 02/2013 - 06/2001
2	Insulin ReceptorIBA 06/2011 - 06/2001
2	Insulin-Like PeptidesIBA 01/2009 - 06/2001
2	AntibodiesIBA 04/2004 - 05/2000
1	Air Pollutants (Pollutants, Air)IBA 06/2022
1	Nitrogen DioxideIBA 06/2022
1	Circulating Tumor DNAIBA 01/2021
1	Biological ProductsIBA 01/2018
1	MethyltransferasesIBA 01/2018
1	Long-Acting Insulin (Insulin, Long Acting)FDA Link 01/2018
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2018
1	Insulin Glargine (Lantus)FDA Link 01/2018
1	Temozolomide (Temodar)FDA LinkGeneric 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	Folic Acid (Vitamin M)FDA LinkGeneric 12/2015
1	ferrous sulfate FDA Link 12/2015
1	Thiamine (Aneurin)FDA Link 12/2015
1	Spironolactone (Aldactone)FDA LinkGeneric 02/2014
1	Testosterone (Sustanon)FDA Link 02/2014
1	AldosteroneIBA 03/2013
1	Estrogens (Estrogen)FDA Link 02/2013
1	Estrogen ReceptorsIBA 02/2013
1	Cyclin D1IBA 02/2013
1	AdiponectinIBA 08/2010
1	Glucose (Dextrose)FDA LinkGeneric 08/2010
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2009
1	ThiazolidinedionesIBA 01/2009
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 01/2009
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2009
1	ProlactinIBA 04/2008
1	Dopamine Agonists (Dopamine Agonist)IBA 04/2008
1	Anticonvulsants (Antiepileptic Drugs)IBA 04/2007
1	HydrocarbonsIBA 04/2006
1	KeroseneIBA 04/2006
1	Hydrocortisone (Cortisol)FDA LinkGeneric 06/2005
1	Dehydroepiandrosterone (DHEA)IBA 03/2003
1	RacivirIBA 01/2002
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 08/2001
1	Proto-Oncogene Proteins c-metIBA 08/2001
1	N 30IBA 08/2001
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 06/2001
1	Thyroglobulin FDA Link 05/2000
1	anti-thyroglobulinIBA 05/2000

Therapy/Procedure

5	Therapeutics 06/2012 - 06/2000
2	Thyroidectomy 06/2000 - 05/2000
1	Neoadjuvant Therapy 01/2021
1	Salvage Therapy 01/2018
1	Aftercare (After-Treatment) 02/2014
1	Caloric Restriction 06/2005
1	Lymph Node Excision (Lymph Node Dissection) 05/2000